Work

S1991 Long-Term Comparative Outcomes of TNF-α Antagonists vs Vedolizumab as First-Line Therapy for Refractory Ulcerative Proctitis: A Propensity-Matched Study

Year: 2025

Type: conference-abstract

Source: The American Journal of Gastroenterology

DOI: 10.14309/01.ajg.0001135424.18331.0d

Authors: Ayushi Jayesh Shah, Ahmad Nawaz, Abdelkader Chaar, Avleen Kaur, Savio John, Idan Goren

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4417197950

Cites:

Cited by:

Related to: